Advanced Search


Study ID Status Title Patient Level Data
201223 Active, Not Recruiting Study 201223 - Interim Meta-analysis of BEL112233, BEL112234, BEL110751 and BEL110752
201224 Completed Meta-Analysis Plan for GSK1550188, 201224, Concomitant Medications Analysis
201228 Active, not recruiting A phase I/II clinical trial of hematopoietic stem cell gene therapy for the Wiskott-Aldrich syndrome
201232 Not yet recruiting Evaluation of use of belimumab in clinical practice settings: Observations from Switzerland
201233 Completed Meta-analysis of DB2116132 and DB2116133. An integrated review to evaluate dose reponse of GSK573719 administered once daily in subjects with COPD
201234 Completed Immunogenicity and safety study of GSK Biologicals’ quadrivalent influenza vaccine (GSK2282512A) compared to Fluzone® Quadrivalent in children 6 to 35 months of age Study Listed on
201235 Completed PRJ2215: Assessment of Buproprion Misuse/Abuse 2004-2011
201244 Completed A randomized, double-blinded study to evaluate the ability of an acne treatment product to produce visible improvements in acne lesions over a 5 day period of once-daily use
201246 Completed A Phase I, Randomised, Double-blind (sponsor open), Placebo-Controlled Single Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK2330811 in Healthy Subjects
201247 Recruiting A multi-center, randomized, double-blind (sponsor open), placebo-controlled, repeat-dose, proof of mechanism study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics and explore efficacy of GSK2330811 in participants with diffuse cutaneous systemic sclerosis
201248 Completed An enabling study to compare the Inhalation Profiles of women in the third stage of labour to those of non-pregnant female volunteers and to explore whether there are any differences which could impact the delivery of an Inhaled medicinal product
201251 Completed Safety and immunogenicity study of GSK Biologicals’ Quadrivalent Influenza Candidate Vaccine (GSK23211381A) manufactured with a new process in adults and children
201274 Withdrawn A Phase I, Two-part, Open-label Study to Evaluate the Pharmacokinetics of Rilapladib (SB-659032) and its Metabolites, and to Determine the Effect of Repeat Dose Itraconazole on the Pharmacokinetics of Rilapladib in Healthy Volunteers
201275 Recruiting ALDREB Drug Use Investigation
201280 Active, Not Recruiting Evidence synthesis to assess comparative efficacy of UMEC versus other treatments for COPD adult patients
201281 Completed An observer-blind study to evaluate the safety, reactogenicity and immunogenicity of the investigational GSK Biologicals’ GSK3277511A vaccine in adults.
201282 Not yet recruiting Evaluation Of Use of Belimumab in Clinical Practice SEttings (OBSErve)
201283 Completed An Exploratory Study to Investigate the Use of Biotelemetry to Identify Markers of Disease Progression in Subjects with Amyotrophic Lateral Sclerosis
201287 Completed A Randomized, Double-blind, Single-dose, Crossover Study to Compare Two Albiglutide Drug Products for Bioequivalence in Healthy Adult Subjects
201294 Withdrawn Pharmacokinetic and Pharmacodynamic Study of Intravenous Augmentin 2.2g in Thai Healthy Volunteers
201295 Active, Not Recruiting Quality-adjusted Time Without Symptoms or Toxicity (Q-TWiST) Analysis of COMPARZ Data
201300 Withdrawn An observer-blind study to evaluate the safety and immunogenicity of GSK Biologicals’ influenza vaccine(s) GSK3277510A and GSK3277509A administered in adults 18 to 60 years of age
201302 Terminated A Phase 1 double-blind, randomised, placebo-controlled, dose escalating study to assess the safety and tolerability of single and multiple oral doses of CHR-5154 and the effect of the fasted and fed state on pharmacokinetics of CHR-5154 and CHR-5426 in healthy male volunteers
201304 Not yet recruiting DUAC Drug Use Investigation
201306 Relinquished PH+oeBE-Patterns of care in HER2+ metastatic Breast cancer in Europe: patients: A representative, retrospective study in Italy



For more information on this register please email

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party. is a database that provides summary protocol information for ongoing clinical trials. is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.